Browse > Article

Effects of Gamigukihwandong-hwan on Renal Function, Oxidative Stress and Polyol Pathway in Diabetic Nephropathy Rats  

Jeong, Hyung-Cheol (Department of Internal Medicine, College of Korean Medicine, Dongguk University)
Jeong, Ji-Cheon (Department of Internal Medicine, College of Korean Medicine, Dongguk University)
Publication Information
Journal of Physiology & Pathology in Korean Medicine / v.21, no.3, 2007 , pp. 671-678 More about this Journal
Abstract
Diabetes is a disease in which the body does not produce or properly use insulin. Etiological studies of diabetes and its complications showed that oxidative stress might play a major role. Therefore, many efforts have been tried to regulate free oxygen radicals for treating diabetes and its complications. Gamigukihwandong-hwan has been known to be effective for the treatment of diabetes. The present study was carried out to investigate the effect of Gamigukihwandong-hwan on renal function, peroxynitrite (ONOO$^-$) scavenging activity and polyol pathway in streptozotocin-induced diabetic rats. The crushed Gamigukihwandong-hwan was extracted 3 times, each time with 3 volumes of methyl alcohol at 60$^{\circ}C$ for 24 h. The extract was filtered and evaporated under a reduced pressure using a rotary evaporator to yield 74.95 g. Gamigukihwandong-hwan extract was oral-administered 100 mg per 1 kg of body weight for 20 days to the diabetic rats induced by streptozotocin (60 mg/kg). The effects of Gamigukihwandong-hwan extract on the streptozotocin-induced diabetic rats were observed by measuring the serum level of glucose, insulin, lipid components, creatinine and BUN, and also the kidney levels of superoxide anion radical (${\cdot}O_2^-$), nitric oxide (NO) and ONOO$^-$, and also the enzyme activities involved in polyol pathway. The Effects of Gamigukihwandong-hwan on the streptozotocin-induced diabetic rats with regards to body weight, blood glucose and insulin levels, creatinine and BUN levels, total cholesterol and triglyceride levels, and HDL-cholesterol levels were all shown to be good enough to cure and prevent the diabetes and its complications. Gamigukihwandong-hwan inhibited the generation of ${\cdot}O_2^-$, NO and ONOO$^-$ in the kidney of streptozotocin-induced diabetic rats. Renal aldose reductase and sorbitol dehydrogenase activities were increased in the streptozotocin-induced diabetic rats, whereas the ones in the Gamigukihwandong-hwan administered group among the streptozotocin-induced diabetic rats were reversed toward the natural activities. Gamigukihwandong-hwan might inhibit the development of diabetic nephropathy by scavenging reactive oxygen and nitrogen species, thereby by reducing oxidative stresses and also by regulating the activities of polyol pathway enzymes, all of which could help to recover the function of kidney.
Keywords
Gamigukihwandong-hwan; diabetes; streptozotocin; renal function; oxidative stresses; peroxynitrite; polyol pathway;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Baynes, J.W. Role of oxidative stress in development of complications in diabetes. Diabetes. 40: 405-412, 1991   DOI   ScienceOn
2 Maureen, I.H. and Michaela, M. Screening for NIDDM. Diabetes Care. 17: 440-444, 1994   DOI
3 김응진 외. 당뇨병학. 서울, 고려의학, pp 15-43, 32-33, 149-169, 391-468, 475-487, 609-616, 1998
4 Beckman, J.S., Beckman, T.W., Chen, J., Marshall, P.A. and Freeman, B.A. Apparent hydroxyl radical production by peroxynitrite : implications for endothelial injury from nitric oxideand superoxide. Proc Natl Acad Sci USA. 87: 1620-1624, 1990
5 강석봉. 消渴의 傳變證과 당뇨병의 만성합병증에 대한 비교 고찰. 대한한의학회지 19(2):137-152, 1998
6 朱 橚. 普濟方. 서울, 翰成社, p 3339, 1995
7 Cathcart, R., Schwiers, E., Ames, B.N. Detection of picomole levels of hydroperoxides using a fluorescent dichlorofluorescein fluorescent assay. Anal Biochem. 134: 111-116, 1983   DOI   ScienceOn
8 Nagata, N., Momose, K., Ishida, Y. Inhibitory effects of catecholamines and anti- oxidants on the fluorescence reaction of 4,5-diaminofluorescein, DAF-2, a novel indicator of nitric oxide. J Biochem Tokyo. 125: 658-661, 1999   DOI
9 Viberti, G.C., Wiseman, M.J. The kidney in diabetes : Significance of the early abnormalities. Clin Endocrinol Metab. 15: 753-760, 1986   DOI
10 Paller, M.S., Neumann, T.V. Reactive oxygen species and rat renal epithelial cells during hypoxia and reoxygeneration. Kidney Int. 40: 1041-1049, 1991   DOI   ScienceOn
11 黃春林 外. 心腎疾病臨證證治. 廣東, 廣東人民出版社, p 316, 2000
12 吳儀洛. 本草從新. 上海, 上海科學技術出版社, pp 22-23, 67, 180, 1982
13 Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-development diabetes mellitus. N Engl J Med. 329: 977-986, 1993   DOI   ScienceOn
14 王毅, 靳長金 朱君波 編著. 益壽效方 120. 北京, 中國醫藥科技出版社, pp 31-32, 95, 1989
15 王其飛 外. 中醫長壽學. 遼寧, 遼寧科學技術出版社, pp 53-54, 327-329, 331-334, 1989
16 Viberti, G.C., Walker, J.D. Diabetic nephropathy : etiology and prevention. Diabetes/Metab Rev. 4: 147-159, 1988   DOI   ScienceOn
17 대한신장학회 등록위원회. 우리나라 신대체요법의 현황. 대한신장학회지 21(suppl 2):S189-203, 2002
18 김형준, 윤철호, 정지천. 珍糖元의 고혈당 조절 작용 및 기전에 관한 연구. 대한한방내과학회지 25(2):277-287, 2004
19 王浴生. 中藥藥理與應用. 北京, 人民衛生出版社, pp 741-743, 998-1000, 1983
20 李尙仁. 本草學. 서울, 醫藥社, pp 71, 74, 118-119, 207, 1981
21 Kooy, N.W., Royall, J.A., Ischiropoulos, H., Beckman, J.S. Peroxynitrite-mediated oxidation of dihydrorhodamine 123. Free Radic Res Commun. 16: 149-156, 1994
22 Flether, M.J. A colorimetric method for estimation serum triglyceride. Clin. Chem. 22: 393, 1968
23 Levinson, S.S. Use of an enzymatic method for cholesterol, designed for continuous flow instrumention, with discrete bichromatic and centrifugation analysis. Clin. Chem. 23: 2335-2337, 1977
24 陳以平. 腎病的辨證與辨病治療. 北京, 人民衛生出版社, pp 143-161, 2003
25 Pugliese, G., Tilton, G.T. and Williamson, J.R. Glucose-induced metabolic imbalance in the pathogenesis of diabetic vascular disease. Diabetes Metab Rev. 7: 35-59, 1991   DOI   ScienceOn
26 余永譜. 中醫治療內分泌代謝疾病. 浙江, 浙江科學技術出版社, p 239, 243, 1992
27 이철웅, 정지천, 신현철. 고혈당 흰쥐에서 蠐螬의 혈당 조절과 항산화작용에 관한 연구. 대한한의학회지 27(1):91-103, 2006
28 Bennai, F., Morsing, P., Paliege, A., Ketteler, M., Mayer, B., Tapp, R., Bachmann, S. Normalizing the expression of nitric oxide synthase by low dose AT1 receptor antagonism parallels improved vascular morphology in hypertensive rats. J Am Soc Nephrol. 10(Suppl 77):S104-115, 1999
29 Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, R.J. Protein measurement with folin phenol reagent. J Biol Chem. 193: 265-275, 1951
30 Stevens, M.J., Dananberg, J., Feldman, E.L., Lattimer, S.A., Kamijo, M., Thomas, T.P., Shindo, H., Sima, A.A. and Greene, D.A. The linked roles of nitric oxide, aldose reductase and Na-K-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat. J Clin Invest. 94: 853-859, 1994   DOI   ScienceOn
31 Noh, H., Ha, H., Yu, M.R., Kang, S.W., Choi, K.H., Han, D.S., Lee, H.Y. High glucose increase inducible NO production in cultured rat mesangial cells. Nephron. 90: 78-85, 2002   DOI   ScienceOn
32 何紹奇, 宋乃光 編著. 中老年保健養生方. 北京, 學苑出版社, pp 208-209, 219-220, 2002
33 Yamaoka, T., Nishimura, C., Yamashita, K., Itakura, M., Yamada, T., Fujimoto, J. and Kokai, Y. Acute onset of diabetic pathological changes in transgenic mice with human aldose reductase cDNA. Diabetologia. 38: 255-261, 1995   DOI   ScienceOn
34 Yagoob, M., McClelland, P., Patrick, A.W., Stevenson, A., Mason, H., White, M.C., Bell, G.M. Evidence of oxidant injury and tubular damage in early diabetic nephropathy. Q. J. Med. 87: 601-607, 1994
35 方藥中. 實用中醫內科學. 上海, 上海科學技術出版社, p 477, 1986
36 廬祥之 編著. 益壽延年二百方. 北京, 中國中醫藥出版社, p 150, 1991
37 Wardle, E.n. Cell biology and the function changes of diabetic nephropathy. Nephrol Dial Transplant. 7: 889-895, 1992   DOI
38 Miller, B.F. and Dubos, R. Studies on the presence of creatinine in human blood. J. Bio. Chem., 121: 447, 1937
39 Thomson, R.H. Colorimetric glucose oxidase method for blood glucose. Clin Chem Acta. 13: 133-135, 1966   DOI   ScienceOn
40 Hammers, H.D., Martin, S., Fedesrlin, K., Geisen, K. and Brownlee, M. Aminoguanidine treatment inhibit the development of experimental diabetic retinopathy. Proc Natl Acad Sci USA. 88: 11555-11558, 1991
41 Hollmann, S. In Hoppe-Seyler Thiefelder : Handbuch der physiol. und path.-chem. Vol. VIa. Berlin-Heidelberg-New York, Analyse Springer. p 704, 1964
42 Tietz, N.W. Fundamentals of clinical chemistry. Philadelphia, W. B. Saunders Company, pp 991-998, 1976